Page 435 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer

Appendix Table C3.2. KQ3 multivariable analyses (continued)
Author Factors Data source Duration Analyzed Population WW/AS Methods Results as described in paper
yr sample characteristics definitions
PMI
77
Hamilton Clinical; SEER-POC 2002 1139 Clinically No therapy multivariate 1. Age ≥75 vs. <60 OR=8.8 (CI
2011 geographic localized within 4 mo logistic 2.9, 26.76), P=0.008 (trend)
20735387 prostate cancer of dx regression 2. Not married vs. married
predicts WW OR=2.19 (1.03, 4.66), P=0.04
vs. any other 2. New Jersey vs. California
treatment OR=3.56 (CI 1.15, 11.03)
3. PSA ≥20 vs. ≤4.0 OR=0.18
(CI 0.04, 0.78), P=0.003
4. Gleason 8-10 vs. <6 OR=0.04
(CI 0.00, 0.32), P=0.03
5. Comorbidities ≥1 vs. 0
OR=0.26 (CI 0.08, 0.89), P=0.03

NS: race

C-135